Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 24, 2004 - Issue 1
Submit an article Journal homepage
20
Views
7
CrossRef citations to date
0
Altmetric
Gynaecology

Raloxifene inhibits cholesterol aortic content but not atherosclerotic plaque size in oophorectomised cholesterol-fed rabbits

C Castelo-Branco Department of Gynecology and Obstetrics, Menopause Clinic, Hospital Clínic Provincial, University of Barcelona, SpainCorrespondence[email protected]
,
A Sanjuán Department of Gynecology and Obstetrics, Menopause Clinic, Hospital Clínic Provincial, University of Barcelona, Spain
,
Elena Casals Department of Biochemistry, Hospital Clínic Provincial, University of Barcelona, Spain
,
C Ascaso Public Health Department, Hospital Clínic Provincial, University of Barcelona, Spain
,
Marta Colodrón Department of Gynecology and Obstetrics, Menopause Clinic, Hospital Clínic Provincial, University of Barcelona, Spain
,
JJ Vicente Department of Gynecology and Obstetrics, Menopause Clinic, Hospital Clínic Provincial, University of Barcelona, Spain
,
Immaculada Mercader Department of Biochemistry, Hospital Clínic Provincial, University of Barcelona, Spain
,
G Escaramís Public Health Department, Hospital Clínic Provincial, University of Barcelona, Spain
,
JE Blümel Climacteric Unit, Barros Luco-Tradeau Hospital, Santiago, Chile
,
J Ordi Pathology Department, Hospital Clinic Provincial, University of Barcelona, Spain
&
JA Vanrell Department of Gynecology and Obstetrics, Menopause Clinic, Hospital Clínic Provincial, University of Barcelona, Spain
 show all
Pages 47-51 | Published online: 02 Jul 2009

References

  • Barrett-Connor E., Wenger N.K., Grady D., Mosca L., Collins P., Kornitzer M., Cox D.A., Moscarelli E. and Anderson P. W. (1998) Coronary heart disease in women, randomized clinical trials, HERS and RUTH. Maturitas, 31, 1–7.
  • Bjarnason N.H., Haarbo J., Byrjalsen I., Kauffman R.F. and Christiansen C. (1997) Raloxifene inhibits aortic accumula-tion of cholesterol in ovariectomised, cholesterol-fed rabbits. Circulation, 96, 1964— 1969.
  • Bjarnason N.H., Haarbo J., Byrjalsen I., Kauffman R.F., Knadler M.P. and Christiansen C. (2000) Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomised, cholesterol-fed rabbits. Clinical Endocrinol-ogy, 52, 225–233.
  • Castelo-Branco C., Casals E., Sanllehy C., Fortuny A., Vanrell J.A. and González-Merlo J. (1995) Postmenopausal estrogen replacement therapy with low dose medroxyprogesterone acetate. Endometrium, plasma lipids, lipoproteins and apolipoproteins. Journal of Reproductive Medicine, 40, 305–311.
  • Clarkson TB., Anthony M.S. and Jerome C.P. (1998) Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys. Journal of Clinical Endocrinology and Metabolism, 83, 721 — 726.
  • Cohen F.J., Watts S., Shah A., Akers R. and Plouffe L. Jr (2000) Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60. Obstetrics and Gynecology, 95, 104 — 110.
  • Felton C.V., Crook D., Davies M.J. and Oliver M.F. (1997) Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arteriosclerosis, Thrombo-sis, and Vascular Biolology, 17, 1337— 1345.
  • Figtree G.A., Lu Y., Webb C. and Collins P. (1999) Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation, 100, 1095–1101.
  • Folch J., Lees M. and Stanley G.H.S. (1957) A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry, 226, 497 — 509.
  • Folsom A.R., Nieto F.J., McGovern PG., Tsai MX., Malinow MR., Eckfeldt J.H., Hess D.L. and Davis C.E. (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities Study. Circulation, 98, 204— 210.
  • Haarbo J., Leth-Espensen P., Stender S. and Christiansen C. (1991) Estrogen monotherapy and combined estrogen-pro-gestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomised cholesterol-fed rabbits. Journal of Clinical Investigation, 87, 1274— 1277.
  • Lee R.T. and Libby P. (1997) The unstable atheroma. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 1859–1867.
  • Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • Mendelsohn M.E. and Karas R.H. (1999) The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340, 1801–1811.
  • Pines A., Mijatovic V., van der Mooren M.J. and Kenemans P. (1997) Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. European Journal of Obstetrics, Gynaecology and Reproductive Biology, 71, 193— 197.
  • Rekhter M.D., Hicks G.W., Brammer D.W., Work C.W., Kim J.S., Gordon D., Keiser J.A. and Ryan M.J. (1998) Animal model that mimics atherosclerotic plaque rupture. Circulation Research, 83, 705–713.
  • Ridker P.M., Buring J.E., Shih J., Matias M. and Hennekens C.H. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 98, 731 —733.
  • Sarrel P.M. (1990) Ovarian hormones and the circulation. Maturitas, 12, 287–298.
  • Stampfer M.J. and Colditz G.A. (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Medicine, 20, 47 —63.
  • Walsh B.W., Kuller L.H., Wild R.A., Paul S., Farmer M., Lawrence J.B., Shah A.S. and Anderson P.W. (1998) Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. Journal of the American Medical Association, 279, 1445 — 1451.
  • Walsh B.W., Paul S., Wild R.A., Dean R.A., Tracy R.P., Cox D.A. and Anderson P.W. (2000) The effects of hormone replacement therapy and raloxifene on C-Reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. Journal of Clinical Endocrinol-ogy and Metabolism, 85, 214–218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.